Navigation Links
Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting

Data on six products from Pharmion's pipeline provide support for epigenetic and combination therapies, including promising Phase III data on use of Thalidomide to treat multiple myeloma

BOULDER, Colo., May 31, 2007 /PRNewswire-FirstCall/ -- Pharmion Corporation reported today that data from 18 abstracts of studies investigating the company's marketed and pipeline products will be presented or published at the American Society of Clinical Oncology's (ASCO) 43rd Annual Meeting in Chicago (June 1-5, 2007). These abstracts include summaries of data from studies of each of the six key products in the company's commercial and development portfolio, for multiple indications, including Myelodysplastic Syndromes (MDS), multiple myeloma, Hodgkin's lymphoma, small cell lung cancer and advanced hormone-refractory prostate cancer.

"ASCO 2007 provides further evidence of Pharmion's progress," said Patrick J. Mahaffy, president and chief executive officer of Pharmion. "Data from six of our products will be presented or published, including Phase III data for Satraplatin and Thalidomide, encouraging Phase II data for Amrubicin, Vidaza and MGCD0103, and human bioavailability data for oral azacitidine. These data demonstrate the strength of the Pharmion business model; we are focused solely on oncology, we have multiple compounds demonstrating clinical benefit, and we have a U.S. and international infrastructure to support those products. Pharmion is well-positioned to take full advantage of the strong portfolio of products in our pipeline."

"The data at ASCO affirm Pharmion's leadership in developing epigenetic therapies as a promising approach to treating cancer," said Andrew R. Allen, Pharmion's chief medical officer. "MGCD0103, our class-selective HDAC inhibitor, is showing meaningful activity as monotherapy in advanced Hodgkin's lymphoma. Furthermore, as we begin to understand the way in which multiple epigen
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
2. The Past, Present and Future of HLA Typing
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
11. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference

Post Your Comments:
(Date:11/6/2009)... Watson Pharmaceuticals, ...ical company, announced today that Paul Bisaro, Wa... provide an overview and update of the Company,s b...e Conference on Wednesday, November 11, 2009 at 12...ion will be webcast live and can be accessed on Wa...
(Date:11/6/2009)...RNewswire-FirstCall/ -- Roper Industries, Inc. (...definitive agreement to acquire Verathon, Inc., a ...The Verathon Board of Directors has approved the t... regulatory approvals and closing conditions, incl...e closing to be completed in early December. ,...
(Date:11/6/2009)...swire-USNewswire/ -- America,s Specialty Medicines...d-market and smaller innovator pharmaceutical comp...he "Affordable Health Care for America Act," intro...ller companies fear that the cumulative effect of ...r efforts to bring new medicines to market. ,...
Breaking Medicine Technology:Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 2Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 3Statement of America's Specialty Medicines Companies On House Health Care Bill (H.R. 3962) 2Covering Kids 26 Families with Health Insurance is Goal of Back to School Outreach Campaign 54850 1Covering Kids 26 Families with Health Insurance is Goal of Back to School Outreach Campaign 54850 2Foreclosures Plunge People Into Depression 54848 1Foreclosures Plunge People Into Depression 54848 2CareTech Expands Services to Garden City Hospital With Radiology Workflow Technology 54843 1CareTech Expands Services to Garden City Hospital With Radiology Workflow Technology 54843 2CareTech Expands Services to Garden City Hospital With Radiology Workflow Technology 54843 3
(Date:11/8/2009)..., WASHINGTON, Nov. 7 ...upak, Pitts, Kaptur, Dahlkemper, Smith, Ellsworth ...are for America Act" (H.R. 3962). The amendment ma...unding for abortion and for benefits packages that...both those who receive affordability credits and t...
(Date:11/8/2009)..., Nation,s largest network of Hispanic health ... care reform in 2009 ,, WASHINGTON, Nov. 7 /PR... Representatives showed they have heard the voice ...alth Care for America Act. Now the Senate must del...health care reform," said Dr. Jane L. Delgado, Pre...
(Date:11/8/2009)..., WASHINGTON, Nov. 8 ...ica (PhRMA) Senior Vice President Ken Johnson rele...ealth care reform bill: ,, "We are disappointed...ss echoed by millions of hardworking Americans as ...se of Representatives who voted against the bill. ...
(Date:11/8/2009)..., WASHINGTON, Nov. 8 ..., Director, Operation Rescue Insurrecta Nex. ,...ntry have been fighting to keep child-killing by a..., Mr. Terry states: "This is a great first step ...but we have a lot of fighting ahead of us. Our rej...
(Date:11/8/2009)..., Health Care Vote Shows Who Sides With Workin...RG, Pa., Nov. 8 On the ...of Representatives for a good, balanced health car...ts scoring of how our state,s U.S. representatives...America Act. ,, The legislation, which passed ...
Breaking Medicine News(10 mins):Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2
...itish schools are concerned that children in prima...patched experts to schools to tackle inappropriate...ven have been interacting with each other in a rat...rmingham say that the local council's inappropriat...
...evices that contain higher doses of copper are mor... lower copper doses, according to a new systematic...g the copper content does not cause an increase in... effectiveness and similar side effect profile wit...
... with industry, University at Buffalo researchers ...lity tests of "allergy-friendly" hotel rooms.// ...able to other environments where indoor air qualit...in Amherst as their laboratory, the Industry-Unive...
... the University of Hong Kong say that the elderly ...ograms because of their age. It is generally felt/... chances of recovery. But the current study ...vors who received rehabilitation in Hong Kong from...
...e use of anesthetics have been recommended by most...n Academy of Pediatrics, for pain relief during in...doctors who are taught circumcision techniques are...s that 97 percent of these doctors now learn effec...
...mb today launched a new vision correction technolo...gery sight distortions. // "There are 60 cli... to treat eye ailments. The technology can be upgr...iness Rajat Goel told reporters here. The com...
Other Medicine News:Health News:Higher-Dose Copper IUDs Provide Better Pregnancy Protection 2Health News:Higher-Dose Copper IUDs Provide Better Pregnancy Protection 3Health News:Scientists Put "Allergy-Friendly" Hotel Rooms to the Test 2Health News:Scientists Put "Allergy-Friendly" Hotel Rooms to the Test 3Health News:Pain Relief During Circumcision 2
Novalis
Platinum Plus
Clinac 23EX
Clinac 2300 C/D Family
Medicine Products: